APA

Hebbar M., Chibaudel B., André T., Mineur L., Smith D., Louvet C., Dutel J. L., Ychou M., Legoux J. L., Mabro M., Faroux R., Auby D., Brusquant D., Khalil A., Truant S., Hadengue A., Dalban C., Gayet B., Paye F., Pruvot F. R., Bonnetain F., Taieb J., Brucker P., Landi B., Flesch M., Carola E., Martin P., Vaillant E. & de Gramont A. (20160224). FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Hebbar M, Chibaudel B, André T, Mineur L, Smith D, Louvet C, Dutel J L, Ychou M, Legoux J L, Mabro M, Faroux R, Auby D, Brusquant D, Khalil A, Truant S, Hadengue A, Dalban C, Gayet B, Paye F, Pruvot F R, Bonnetain F, Taieb J, Brucker P, Landi B, Flesch M, Carola E, Martin P, Vaillant E and de Gramont A. 20160224. FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Hebbar M., Chibaudel B., André T., Mineur L., Smith D., Louvet C., Dutel J. L., Ychou M., Legoux J. L., Mabro M., Faroux R., Auby D., Brusquant D., Khalil A., Truant S., Hadengue A., Dalban C., Gayet B., Paye F., Pruvot F. R., Bonnetain F., Taieb J., Brucker P., Landi B., Flesch M., Carola E., Martin P., Vaillant E. and de Gramont A. (20160224). FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Hebbar M, Chibaudel B, André T, Mineur L, Smith D, Louvet C, Dutel J L, Ychou M, Legoux J L, Mabro M, Faroux R, Auby D, Brusquant D, Khalil A, Truant S, Hadengue A, Dalban C, Gayet B, Paye F, Pruvot F R, Bonnetain F, Taieb J, Brucker P, Landi B, Flesch M, Carola E, Martin P, Vaillant E and de Gramont A. FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial. : Annals of oncology : official journal of the European Society for Medical Oncology. 20160224.